Therefore, our clinical data strongly suggested that C1GALT1 could be a potential good prognostic marker for NB patients and the underlying mechanism by which C1GALT1 affects phenotypic changes of NB may be through TrkA signaling. The gene discussed is NTRK1; the disease is neuroblastoma.